Peter Noseworthy, MD
机构: Chair, Electrophysiology, Professor of Medicine, Mayo Clinic
主页: mayo.edu
每年引用次数
引用次数
引用: 22,724
H-指数: 74
I10-指数 : 246
出版物: 661
Artificial intelligence-derived physiological aging is associated with coronary endothelial dysfunction
A Ahmad , T Toya , M Corban , Z.I Attia
European Heart Journal 41
2020
Large Observational Data to Facilitate Personalized Shared Decision Making for a Recently Approved Cardiac Device
Peter A Noseworthy MD ,
2018
Cardiac Device Implantation Post TAVR: Mortality and Rates of Pacemaker Dependency
Deepak Padmanabhan , Mackram Eleid , Abhishek Deshmukh , Christopher Scott
Circulation 132 ( suppl_3) A16562 -A16562
2015
Vascular Aging Detected by Peripheral Endothelial Dysfunction Is Associated With ECG‐Derived Physiological Aging
Peter A Noseworthy , Francisco Lopez‐Jimenez , Amir Lerman , Suraj Kapa
Journal of the American Heart Association 10 ( 3) 1 -15
1
2021
Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure: Results From the CABANA Trial.
Peter A Noseworthy , Tristram D Bahnson , Daniel B. Mark , Kristi H Monahan
Circulation 143 ( 14) 1377 -1390
167
2021
Electrocardiogram screening for aortic valve stenosis using artificial intelligence.
Peter A Noseworthy , Hector I Michelena , Francisco Lopez-Jimenez , Maurice Enriquez-Sarano
European Heart Journal
1
2021
Screening and management of atrial fibrillation in primary care.
Peter A Noseworthy , Victor Montori , Shiva P Ponamgi , Jonathan Graff-Radford
BMJ 373
2021
Shared Decision Making Tools for People Facing Stroke Prevention Strategies in Atrial Fibrillation: A Systematic Review and Environmental Scan.
Peter A Noseworthy , Victor M Montori , Angela Fagerlin , Larry Prokop
Medical Decision Making
2021
Abstract P006: Multimorbidity In Patients With Atrial Fibrillation: A Community Study
Peter A Noseworthy , Veronique L Roger , Susan Weston , Jill Killian
Circulation 143
2021
The 12-lead electrocardiogram as a biomarker of biological age
Bernard J Gersh , Peter A Noseworthy , Francisco Lopez-Jimenez , Jose R Medina-Inojosa
European Heart Journal - Digital Health
2021
Catheter-related complications and mortality of atrial fibrillation ablation following introduction of contact force-sensing technology
Joseph G Akar , James P Hummel , Xiaoxi Yao , Lindsey Sangaralingham
BMJ Surgery, Interventions, & Health Technologies 2 ( 1)
1
2020
Generalizability of the FOURIER trial to routine clinical care: Do trial participants represent patients in everyday practice?
Xiaoxi Yao , Bernard J Gersh , Francisco Lopez-Jimenez , Nilay D Shah
American Heart Journal 209 54 -62
5
2019
Utilization and procedural adverse outcomes associated with Watchman device implantation.
Fouad Khalil , Shilpkumar Arora , Ammar M Killu , Byomesh Tripathi
Europace 23 ( 2) 247 -253
1
2021
To teach an old dog new tricks: The limits of CHA2DS2-VASc in patients with atrial fibrillation and cancer.
Xiaoxi Yao , Peter A Noseworthy
European Journal of Preventive Cardiology 25 ( 9) 994 -995
3
2018
Atrial fibrillation in heart failure syndromes: does it matter more in some than in others?
Konstantinos C Siontis , Xiaoxi Yao , Peter A Noseworthy
European Heart Journal 39 ( 48) 4285 -4286
3
2018
Atrial fibrillation ablation in practice: assessing CABANA generalizability.
Peter A Noseworthy , Bernard J Gersh , David M Kent , Jonathan P Piccini
European Heart Journal 40 ( 16) 1257 -1264
51
2019
An artificial intelligence-enabled ECG algorithm for the identification of patients with atrial fibrillation during sinus rhythm: a retrospective analysis of outcome prediction.
Zachi I Attia , Peter A Noseworthy , Francisco Lopez-Jimenez , Samuel J Asirvatham
The Lancet 394 ( 10201) 861 -867
688
2019
An AI-ECG algorithm for atrial fibrillation risk: steps towards clinical implementation - Authors' reply.
Peter A Noseworthy , Zachi I Attia , Rickey E Carter , Xiaoxi Yao
The Lancet 396 ( 10246) 236 -237
2020
Effect of tacrine on EEG slowing in the rat: enhancement by concurrent monoamine therapy.
Hans C Dringenberg , Peter Diavolitsis , Peter A Noseworthy
Neurobiology of Aging 21 ( 1) 135 -143
28
2000
Utility of T-wave amplitude as a non-invasive risk marker of sudden cardiac death in hypertrophic cardiomyopathy.
Alan Sugrue , Ammar M Killu , Christopher V DeSimone , Anwar A Chahal
Open heart 4 ( 1)
8
2017